Photochemotherapy

Research in photochemotherapy explores the use of light and photosensitive agents to treat diseases, primarily cancer. Investigations focus on developing novel photosensitizers, understanding their mechanisms of action, and optimizing light delivery systems. This includes synthesizing new compounds, evaluating their efficacy and safety in preclinical models, and exploring their integration with advanced drug delivery platforms. Techniques such as spectroscopy and advanced imaging are employed to monitor treatment response and understand cellular interactions.

This area of study holds relevance for Arkansas by addressing public health challenges, particularly in cancer treatment. The development of innovative therapeutic strategies can improve patient outcomes and potentially reduce healthcare costs within the state. Furthermore, advancements in this field can foster collaborations with the state's growing biotechnology and pharmaceutical sectors, contributing to economic development.

This research is inherently interdisciplinary, drawing on expertise from chemistry, pharmacology, materials science, and biomedical engineering. Investigations are conducted across multiple Arkansas institutions, fostering collaboration and leveraging diverse institutional strengths in areas such as nanoparticle synthesis, advanced biosensing, and Raman spectroscopy for biomedical analysis.